Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RENACTIF: NAC in Chronic Kidney Disease
NCT03636932Phase 2Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Apr 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in chronic kidney disease (CKD), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Apr 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03636932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03636932.